how bpc 157 works BPC-157 Oral vs Injection: Benefits, Bioavailability & Recovery What is BPC-157 and How

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

The preclinical data provide a solid foundation for future investigations into their potential applications in medicine

2017, 85, e00091 10.1128/IAI.00091-17

Histological analysis reveals treated wounds exhibit better organized collagen architecture with reduced excessive scarring